Literature DB >> 20233677

Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer.

Fatma Trifa1, Sondes Karray-Chouayekh, Imed Mabrouk, Sami Baccouche, Abdelmajid Khabir, Tahia Sellami-Boudawara, Ali Gargouri, Raja Mokdad-Gargouri.   

Abstract

BACKGROUND: The p53 polymorphisms have been extensively studied as putative breast cancer susceptibility variants. The present study was undertaken to investigate the association of p53 Arg72Pro, Ins16bp and G13964C polymorphisms and their haplotypes with breast cancer risk in Tunisian women.
METHODS: Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) on 159 patients and 132 controls.
RESULTS: The G13964C intronic variant was significantly associated with familial breast cancer risk (p=0.0018) while the genotypic distribution was similar for p53 Arg72Pro and Ins16bp in patients and controls. Moreover, the (NoIns-C), (Arg-C) and (NoIns-Arg-C) haplotypes were significantly associated with familial breast cancer risk (p=0.0021, p=0.0096 and p=0.0084, respectively) while there was a trend of association between the (Ins-Arg) and (Ins-Arg-G) haplotypes and the risk of sporadic breast cancer. Only the G/C genotype as well as the (NoIns-C) haplotype remained significant after correction for multiple testing.
CONCLUSION: Our data revealed an association between the G/C genotype and the (NoIns-C) haplotype and the risk of familial breast cancer in Tunisian women. However, these observations need to be confirmed due to the limited statistical power of our study and the small number of cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233677     DOI: 10.1016/j.canep.2010.02.007

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  10 in total

1.  Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.

Authors:  Hongtao Cheng; Biao Ma; Ran Jiang; Wei Wang; Hui Guo; Na Shen; Dapeng Li; Qunzi Zhao; Rui Wang; Pengfei Yi; Yue Zhao; Zeming Liu; Tao Huang
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.

Authors:  Patricia Rodrigues; Jessica Furriol; Eduardo Tormo; Sandra Ballester; Ana Lluch; Pilar Eroles
Journal:  Mol Cell Biochem       Date:  2013-04-06       Impact factor: 3.396

3.  Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.

Authors:  Tatiana Dantas Rodrigues Laprano; Erika Hardy Lemos; Lia Moreira Pinto Cunha; José Eleutério Júnior; Rosiane Alves de SousaTeles; Silvia Helena Barem Rabenhorst
Journal:  Tumour Biol       Date:  2014-04-30

4.  Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.

Authors:  Roghayeh Dehghan; Mohammad Ali Hosseinpour Feizi; Nasser Pouladi; Esmaeil Babaei; Vahid Montazeri; Ashraf Fakhrjoo; Ayda Sedaei; Parvin Azarfam; Masoumeh Nemati
Journal:  Pathol Oncol Res       Date:  2014-11-20       Impact factor: 3.201

5.  Intron 3 sixteen base pairs duplication polymorphism of p53 contributes to breast cancer susceptibility: evidence from meta-analysis.

Authors:  Dongmei Wu; Zhizhong Zhang; Haiyan Chu; Ming Xu; Yao Xue; Haixia Zhu; Zhengdong Zhang
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

6.  Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis.

Authors:  Meire Luzia Gonçalves; Sarah Moreira Borja; Jacqueline Andréia Bernardes Leão Cordeiro; Vera Aparecida Saddi; Flávio Monteiro Ayres; Cesar Augusto Sam Tiago Vilanova-Costa; Antonio Márcio Teodoro Cordeiro Silva
Journal:  Springerplus       Date:  2014-12-17

7.  Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.

Authors:  Brehima Diakite; Yaya Kassogue; Guimogo Dolo; Oumar Kassogue; Mamadou Lassine Keita; Brian Joyce; Erin Neuschler; Jun Wang; Jonah Musa; Cheick Bougari Traore; Bakarou Kamate; Etienne Dembele; Sellama Nadifi; Mercy Isichei; Jane L Holl; Robert Murphy; Seydou Doumbia; Lifang Hou; Mamoudou Maiga
Journal:  BMC Med Genet       Date:  2020-07-03       Impact factor: 2.103

Review 8.  Genetics of breast cancer in African populations: a literature review.

Authors:  A Abbad; H Baba; H Dehbi; M Elmessaoudi-Idrissi; Z Elyazghi; O Abidi; F Radouani
Journal:  Glob Health Epidemiol Genom       Date:  2018-05-11

9.  Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.

Authors:  Chaymaa Marouf; Amal Tazzite; Brehima Diakité; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Tumour Biol       Date:  2014-09-09

10.  Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes.

Authors:  Veronika Vymetalkova; Pavel Soucek; Tereza Kunicka; Katerina Jiraskova; Veronika Brynychova; Barbara Pardini; Vendula Novosadova; Zdena Polivkova; Katerina Kubackova; Renata Kozevnikovova; Miloslav Ambrus; Ludmila Vodickova; Alessio Naccarati; Pavel Vodicka
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.